New Results
Comparing neurotransmitter metabolism in the brain of patients with symptomatic and asymptomatic Alzheimer’s disease and healthy individuals
Stuart G. Snowden, Amera A. Ebshiana, Abdul Hye, An Yang, Olga Pletnikova, Richard O’Brien, John Troncoso, Cristina Legido-Quigley, Madhav Thambisetty
doi: https://doi.org/10.1101/220699
Stuart G. Snowden
aInstitute of Pharmaceutical Sciences, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Amera A. Ebshiana
aInstitute of Pharmaceutical Sciences, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Abdul Hye
bInstitute of Psychiatry, Psychology and Neuroscience, Department of Old Age Psychiatry,King’s College London, Maurice Wohl Clinical Neuroscience Institute, 125 Coldharbour Lane, SE5 9NU, UK.2
An Yang
cClinical and Translational Neuroscience Unit, Laboratory of Behavioural Neuroscience, National Institute on Aging, Baltimore, MD, USA.
Olga Pletnikova
dDivision of Neuropathology Johns Hopkins School of Medicine 720 Rutland Avenue, Ross 558 Baltimore, MD 21205
Richard O’Brien
eDepartment of Neurology, Duke University Medical School
John Troncoso
eDepartment of Neurology, Duke University Medical School
Cristina Legido-Quigley
aInstitute of Pharmaceutical Sciences, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Madhav Thambisetty
cClinical and Translational Neuroscience Unit, Laboratory of Behavioural Neuroscience, National Institute on Aging, Baltimore, MD, USA.
Article usage
Posted December 13, 2017.
Comparing neurotransmitter metabolism in the brain of patients with symptomatic and asymptomatic Alzheimer’s disease and healthy individuals
Stuart G. Snowden, Amera A. Ebshiana, Abdul Hye, An Yang, Olga Pletnikova, Richard O’Brien, John Troncoso, Cristina Legido-Quigley, Madhav Thambisetty
bioRxiv 220699; doi: https://doi.org/10.1101/220699
Comparing neurotransmitter metabolism in the brain of patients with symptomatic and asymptomatic Alzheimer’s disease and healthy individuals
Stuart G. Snowden, Amera A. Ebshiana, Abdul Hye, An Yang, Olga Pletnikova, Richard O’Brien, John Troncoso, Cristina Legido-Quigley, Madhav Thambisetty
bioRxiv 220699; doi: https://doi.org/10.1101/220699
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)